Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -15.90%6.61B | -24.27%7.86B | -44.78%2.05B | -11.30%2.42B | -12.53%10.37B | 1.74B | -24.69%2.18B | 15.75%3.72B | 0.78%2.73B | 7.63%11.86B |
| Cost of revenue | -33.03%1.39B | -47.69%2.07B | -27.55%501.59M | -36.52%534.69M | 50.30%3.96B | 1.09B | 94.30%1.34B | 13.81%692.31M | 38.28%842.25M | 7.58%2.64B |
| Gross profit | -9.75%5.22B | -9.78%5.78B | -48.72%1.55B | -0.08%1.89B | -30.50%6.41B | 644.1M | -61.71%846M | 16.20%3.03B | -10.07%1.89B | 7.65%9.22B |
| Operating expense | -10.30%5.83B | -15.80%6.49B | -20.36%1.49B | -18.64%1.86B | 7.69%7.71B | 1.36B | 20.89%2.19B | 8.77%1.87B | 29.47%2.28B | 9.74%7.16B |
| Staff costs | -17.63%2.03B | -22.71%2.47B | ---- | ---- | 18.47%3.19B | ---- | ---- | ---- | ---- | 6.14%2.7B |
| Selling and administrative expenses | -11.94%2.29B | -9.56%2.6B | ---- | ---- | 33.25%2.87B | ---- | ---- | ---- | ---- | 29.42%2.16B |
| -Selling and marketing expense | 279.82%36.34M | 15.46%9.57M | ---- | ---- | -58.54%8.29M | ---- | ---- | ---- | ---- | 49.95%19.99M |
| -General and administrative expense | -13.02%2.25B | -9.64%2.59B | ---- | ---- | 34.11%2.86B | ---- | ---- | ---- | ---- | 29.25%2.14B |
| Depreciation and amortization | -19.23%66.15M | 20.34%81.89M | ---- | ---- | -84.88%68.05M | ---- | ---- | ---- | ---- | 3.56%450.06M |
| -Depreciation | -19.23%66.15M | 20.34%81.89M | ---- | ---- | -84.88%68.05M | ---- | ---- | ---- | ---- | 3.56%450.06M |
| Rent and land expenses | 1.07%836.43M | 0.10%827.61M | ---- | ---- | 8.20%826.76M | ---- | ---- | ---- | ---- | 19.41%764.14M |
| Other operating expenses | 16.11%602.27M | -31.01%518.71M | ---- | ---- | -31.41%751.81M | ---- | ---- | ---- | ---- | -12.05%1.1B |
| Operating profit | 14.74%-606.45M | 45.40%-711.3M | -94.80%59.99M | 108.39%32.82M | -163.19%-1.3B | -717.88M | -440.78%-1.35B | 30.70%1.15B | -214.95%-391.19M | 0.97%2.06B |
| Net non-operating interest income (expenses) | -186.22%-91.09M | -88.74%-31.83M | -56.13%-8.04M | -17.84%-4.16M | -18.02%-16.86M | -6.26M | 51.12%-1.93M | -96.83%-5.15M | -74.63%-3.53M | -41.31%-14.29M |
| Non-operating interest income | 36.14%2.81M | 562.50%2.07M | 214.72%620K | 97,650.00%1.96M | 68.65%312K | ---2.01M | 106,200.00%2.13M | -88.05%197K | -97.70%2K | -80.15%185K |
| Non-operating interest expense | 177.06%93.91M | 97.35%33.89M | 61.98%8.66M | 73.11%6.12M | 18.66%17.17M | --4.25M | 2.79%4.05M | 25.36%5.34M | 67.52%3.53M | 31.06%14.47M |
| Net investment income | -211.37%-34.78M | 89.00%31.23M | -13.57M | -43.86%7.69M | -67.59%16.52M | 345.30%13.7M | 378.56%50.99M | |||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -115.52%-14.89M | 95.9M | 59.14M | 33.63M | 0 | 0 | 0 | 23.56M | ||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 59.58%-575.01M | -82.44%-1.42B | -398.82M | 7.43M | -27,384.67%-779.74M | -753.93M | 0 | 85.90%-2.84M | ||
| Less:Other special charges | 422.53%256.15M | 38.43%49.02M | --0 | ---7.43M | 1,148.18%35.41M | --9.6M | --0 | ---- | ---- | -85.90%2.84M |
| Less:Write off | -76.79%318.86M | 84.53%1.37B | ---- | ---- | --744.33M | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 3.77%-192.21M | -17.55%-199.75M | -9.75%-50.71M | -3.70%-42.03M | -17.68%-169.93M | -40.65M | -10.58%-42.54M | -34.58%-46.21M | -33.08%-40.53M | -23.96%-144.4M |
| Income before tax | 32.34%-1.51B | 0.64%-2.24B | -133.12%-352.01M | 108.39%35.38M | -214.09%-2.25B | -1.5B | -494.60%-1.39B | 20.96%1.06B | -241.08%-421.55M | 3.62%1.97B |
| Income tax | 108.32%24.92M | -93.37%11.96M | -94.34%21.68M | 91.26%-5.8M | -72.78%180.35M | 261.68M | -443.18%-397.94M | 36.28%383.02M | -152.92%-66.4M | 8.59%662.47M |
| Net income | 31.59%-1.54B | 7.51%-2.25B | -154.98%-373.69M | 111.60%41.18M | -285.44%-2.43B | -1.76B | -519.79%-993.72M | 13.76%679.71M | -304.93%-355.15M | 1.28%1.31B |
| Net income continuous operations | 31.59%-1.54B | 7.51%-2.25B | -154.98%-373.69M | 111.60%41.18M | -285.44%-2.43B | ---1.76B | -519.79%-993.72M | 13.76%679.71M | -304.93%-355.15M | 1.28%1.31B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 31.59%-1.54B | 7.51%-2.25B | -154.98%-373.69M | 111.60%41.18M | -285.44%-2.43B | -1.76B | -519.79%-993.72M | 13.76%679.71M | -304.93%-355.15M | 1.28%1.31B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 31.59%-1.54B | 7.51%-2.25B | -154.98%-373.69M | 111.60%41.18M | -285.44%-2.43B | -1.76B | -519.79%-993.72M | 13.76%679.71M | -304.93%-355.15M | 1.28%1.31B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 41.52%-59.8 | 7.99%-102.26 | -154.83%-17.03 | 111.52%1.87 | -285.33%-111.14 | -80.57 | -518.43%-45.4 | 13.77%31.06 | -305.70%-16.23 | 0.52%59.97 |
| Diluted earnings per share | 41.52%-59.8 | 7.99%-102.26 | -154.83%-17.0307 | 111.52%1.87 | -285.33%-111.14 | -80.66 | -522.33%-45.4417 | 14.36%31.06 | -305.70%-16.23 | 0.52%59.97 |
| Dividend per share | 0 | -50.00%17.5 | 0.00%17.5 | 0 | 16.67%35 | 17.5 | 0 | 16.67%17.5 | 0 | 0.00%30 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |